REVIEW OF CLINICAL SYNDROMES IN COVID-19 IN GLOBAL PERSPECTIVE: A STEP TOWARDS INFECTION PREVENTION CONTROL IN FORENSIC PRACTICES
Keywords:
World Health Organization, World Health Organization (WHO), ToxicologyAbstract
The coronaviruses are a large family comprises of various single stranded RNA (+ssRNA) viruses that can be isolated in different species, some causing human illness including Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS) and others that can cross species barriers and circulate among animals, including camels, cats and bats.1 The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) as it is now called, is rapidly spreading from its origin in Wuhan City of Hubei Province of China to the rest of the world.2,3 Johns Hopkins University and other forums provides the constantly changing case detection rate on daily basis.4 The future course of this virus is not known till date.
References
1. Holmes KV. SARS- Associated coronavirus. N Engl J Med 2003;348:1948–51. doi: https://doi.org/10.1056/ NEJMp030078.
2. World Health Organization. Director General’s remarks at the media briefing on 2019- nCoV on 11 February 2020. secondary director General’s remarks at the media briefing on 2019- nCoV on 11 February 2020, 2020. Available: https://www.who.int/dg/speeches/detail/ who-director-general-s-remarks-at-the-media-briefing on-2019-ncov-on-11-february-2020
3. Gorbalenya AE, Baker SC, Baric RS et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. doi: https://doi.org/10.1038/s41564-020-0695-z.
4. Coronavirus 2019-nCoV, CSSE. Coronavirus 2019- nCoV Global Cases by Johns Hopkins CSSE. (Available from: https://gisanddata.maps.arcgis.com/apps/ opsdashboard/index.html#/bda7594740fd40299423467 b48e9ecf6)
5. Osborn M, Lucas S, Stewart R, et al. Autopsy practice relating to possible cases of COVID-19 (2019- nCov, novel coronavirus from China 2019/2020) secondary autopsy practice relating to possible cases of COVID 19 (2019- nCov, novel coronavirus from China 2019/ 2020), 2020. Available: https://www.rcpath.org/ uploads/assets/d5e28baf-5789-4b0f-acecfe370 eee6223/fe8fa85a-f004-4a0c-81ee4b2b9cd12cbf/ Briefing-on-COVID-19-autopsy-Feb-2020.pdf
6. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497-506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5
7. World Health Organization Health Emergency Dashboard. Available from: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019.
8. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020. https://doi.org/ 10.1056/NEJMc2001468.
9. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its
inactivation with biocidal agents. J Hosp Infect. 2020 Feb 6. pii: S0195–6701(20)30046–3.
10. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020. https://doi.org/10.1056/ NEJMc2001737.
11. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30360-3.
12. Cheng ZJ, Shan J. 2019 novel coronavirus: where we are and what we know. Infection. 2020:1–9. https:// doi.org/10.1007/s15010-02001401-y.
13. World Health Organization in its ‘Global surveillance for COVID-19 caused by human infection with COVID 19 virus: Interim guidance’. Available from: https:// apps.who.int/iris/rest/bitstreams/1272502/retrieve
14. World Health Organization. Interim guidance on clinical management of severe acute respiratory infection when COVID-19 is suspected. Available from: https://apps.who.int/iris/rest/bitstreams/1272156/ retrieve
15. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus– infected pneumonia in Wuhan, China. JAMA. 2020. doi: http://doi.org/10.1001/jama.2020.1585.
16. Chinese Medical Association of Pathologists, Chinese Medical Association Pathology Branch. Guidelines for Autopsy Examination of Coronary Virus Disease 19 Deaths (Trial) [J / OL]. Chinese Journal of Pathology, 2020, 49 (2020- 03-10) DOI: http://doi.org/10.3760/ cma.j.cn112151-20200309-00184.
17. Tian S, Hu W, Niu L, et al. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020: doi: https://doi.org/10.1016/ j.jtho.2020.02.010
18. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine. doi: https://doi.org/10.1016/S2213-2600(20)30076-X.
19. Yao XH , Li TY , He ZC , Ping YF , Liu HW , Yu SC et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020; Mar 15;49(0):E009. doi: https://doi.org/ 10.3760/cma.j.cn112151-20200312-00193.
20. He F, Deng Y, Li W. Coronavirus disease 2019: what we know? Journal of medical virology. 2020. doi: http:/ /doi.org/10.1002/jmv.2576
21. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions
of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR. 2020; 214:1–6. doi: http:// doi.org/10.2214/AJR.20.22976
22. Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020. doi: https://doi.org/10.1148/ radiol.2020200823
23. Lake M. What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine. 2020; 20(2):124–7. doi: https://doi.org/10.7861/ clinmed.2019-coron
24. Finegan O, Fonseca S, Guyomarc’h P, Morcillo M, Gonzalez R, Tidball-Binz, Winter KA, ICRC Advisory Group on the Management of COVID-19 Related Fatalities, International Committee of the Red Cross (ICRC): General Guidance for the Management of the Dead Related to COVID-19, Forensic Science International: Synergy. doi: https://doi.org/10.1016/ j.fsisyn.2020.03.007.
25. European Centre for Disease Prevention and Control, Considerations related to the safe handling of bodies of deceased persons with suspected or confirmed COVID-19, Stockholm; 2020.
26. World Health Organization: Laboratory biosafety manual, Ed 3, 2004; Geneva, WHO. Available from: https://www.who.int/csr/resources/publications/ biosafety/Biosafety7.pdf?ua=1
27. Centers for Disease Control and Prevention: Biosafety in Microbiological and Biomedical Laboratories. Ed 5, 2009; National Institute of Health, U.S. Department of Health and Human Services. Available from: https:// w w w. c d c . g o v / l a b s / p d f / C D C - B i o s a f e t y MicrobiologicalBiomedicalLaboratories-2009-P.PDF
28. Health and Safety Executive Advisory Committee on Dangerous Pathogens. The Approved list of biological agents. secondary the Approved list of biological agents. Available from: www.hse.gov.uk/pubns/ misc208.pdf
29. Hanley B, Lucas SB, Youd E, et al. Autopsy in suspected COVID-19 cases. J Clin Pathol Epub ahead of print: [30 March 2020]. doi: https://doi.org/10.1136/ jclinpath-2020-206522.
30. Standard Operating Procedure and guidelines for 2019- nCoV specimen collection, packaging and transport. Indian Council of Medical Research- National Institute of Virology, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. Available from: https://www.mohfw.gov.in/pdf/ 5Sample%20collection_packaging%20%202019- nCoV.pdf
